Measuring quality of life of Thai men with androgenetic alopecia by Dermatology Life Quality Index
Keywords:
Quality of life, dermatology life quality index, androgenetic alopecia, Thai menAbstract
Background: Although androgenetic alopecia (AGA) is the most common cause of hair loss in men, standardized qualitative reports about impact on Quality of Life (QoL) are lacking. Dermatology Life Quality Index (DLQI) is a simple and practical questionnaire. To our knowledge, there is no report about the impact of AGA on the QoL of Thai men.
Objective: To assess the QoL in Thai men with AGA using DLQI.
Material and Method: This study enrolled fifty Thai men with AGA. Each subject completed DLQI questionnaire within 5 minutes.
Results: The mean (SD) of overall DLQI score was 5.08 (4.56). The highest individual mean score came from Question 2 (embarrassment) while the lowest individual mean score came from Question 9 (sexual difficulties). In this study, severity of AGA and patient age did not significantly influence QoL.
Conclusion: This study demonstrates that AGA in Thai men affects their QoL. The results indicated that AGA had the greatest impact on their feelings or symptoms and the least impact on their personal relationship. Doctors should thoughtfully address the problems when caring for patients with this condition. DLQI is a useful and practical method to evaluate the quality of life of AGA patients.
References
McElwee KJ, Shapiro JS. Promising therapies for treating and/or preventing androgenic alopecia. Skin Therapy Lett 2012; 17:1-4.
Su LH, Chen TH. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010; 163: 371-7.
Acibucu F,Kayatas M,Candan F. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia. Singapore Med J 2010; 51: 931-6.
Tanglertsampan C. Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study. J Med Assoc Thai 2013; 96: 947-51.
Cash TF. The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26: 926-31.
Alfonso M, Richter-Appelt H, Tosti A, Viera MS, García M. The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin 2005; 21: 1829-36.
Wells PA, Willmoth T, Russell RJ. Does fortune favour the bald? Psychological correlates of hair loss in males. Br J Psychol 1995; 86: 337-44.
Selvin ML, Plant H, Lynch D, Drinkwater J & Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988; 57: 109-12.
Finlay AY & Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
Kulthanan K, Jiamton S, Wanitpahakdeedecha R, Chantharujkaphong S. The validity and reliability of Dermatology Life Quality Index (DLQI) in Thais. Thai J Dermatol 2004; 20:113-23.
Basra MKA, Fenech R, Gatt RM, Salek MS & Finlay AY. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997–1035.
Yamazaki M, Miyakura T, Uchiyama M, Hobo A, Irisawa R, Tsuboi R. Oral finasteride improved the quality of life of androgenetic alopecia patients. J Dermatol 2011; 38: 773-7
Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001; 15: 137-9.
Kulthanan K, Jiamton S, Kittisarapong R. Dermatology Life Quality Index in Thai patients with acne. Siriraj Med J 2007; 59: 3-7.
Kulthanan K, Chiawsirikajorn Y, Jiamton S. Acute urticaria: etiologies, clinical course and quality of life. Asian Pac J Allergy Immunol 2008; 26:1-9.
Girman CJ, Rhodes T, Lilly FRW et al. Effects of self-perceived hair loss in a community sample of men. Dermatology 1998; 197: 223–9.
Passchier J. Quality of life issues in male pattern hair loss. Dermatology 1998; 197: 217-8.
Roger EN, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 2008; 59: 547-66.
Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss : a randomized, double-blind, comparative study. J Med Assoc Thai 2012; 95: 1312-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Thai Journal of Dermatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น
